PT103029A - Inibidores de dopamina-beta-hidroxilase selectivos perifericamente e metodo para a sua preparacao - Google Patents
Inibidores de dopamina-beta-hidroxilase selectivos perifericamente e metodo para a sua preparacaoInfo
- Publication number
- PT103029A PT103029A PT103029A PT10302903A PT103029A PT 103029 A PT103029 A PT 103029A PT 103029 A PT103029 A PT 103029A PT 10302903 A PT10302903 A PT 10302903A PT 103029 A PT103029 A PT 103029A
- Authority
- PT
- Portugal
- Prior art keywords
- selective
- beta
- preparation
- hydroxylase inhibitors
- dopamine
- Prior art date
Links
- 108010015720 Dopamine beta-Hydroxylase Proteins 0.000 title 1
- 102100033156 Dopamine beta-hydroxylase Human genes 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/695—Silicon compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/84—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrane Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0223719A GB2393958A (en) | 2002-10-11 | 2002-10-11 | Peripherally-selective imidazole inhibitors of dopamine-beta-hydroxylase |
| GB0224306A GB2394223B (en) | 2002-10-11 | 2002-10-18 | Peripherally-selective inhibitors of dopamine-beta-hydroxylase and method of their preparation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PT103029A true PT103029A (pt) | 2004-05-31 |
| PT103029B PT103029B (pt) | 2005-05-31 |
Family
ID=32031889
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT103029A PT103029B (pt) | 2002-10-11 | 2003-10-10 | Inibidores de dopamina-beta-hidroxilase selectivos perifericamente e metodo paraa sua preparacao |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US7125904B2 (pt) |
| EP (5) | EP1914233B8 (pt) |
| JP (1) | JP4620464B2 (pt) |
| KR (1) | KR101155159B1 (pt) |
| AU (1) | AU2003271945B2 (pt) |
| BR (1) | BRPI0315143B8 (pt) |
| CA (1) | CA2501819C (pt) |
| GB (2) | GB2432159B (pt) |
| MX (1) | MXPA05003847A (pt) |
| PL (1) | PL218537B1 (pt) |
| PT (1) | PT103029B (pt) |
| RU (1) | RU2332416C2 (pt) |
| WO (1) | WO2004033447A1 (pt) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0600709D0 (en) * | 2006-01-13 | 2006-02-22 | Portela & Ca Sa | Drug combinations |
| GB0610804D0 (en) | 2006-05-31 | 2006-07-12 | Portela & Ca Sa | New crystal forms |
| MX2009006113A (es) * | 2006-12-12 | 2009-07-17 | Bial Portela & Ca Sa | Proceso catalitico para hidrogenacion asimetrica. |
| GB0700635D0 (en) * | 2007-01-12 | 2007-02-21 | Portela & Ca Sa | Therapy |
| GB0701966D0 (en) * | 2007-02-01 | 2007-03-14 | Portela & Ca Sa | Process |
| US20100093817A1 (en) * | 2007-02-01 | 2010-04-15 | Bial - Portela & Ca S.A. | Compounds |
| GB0701965D0 (en) * | 2007-02-01 | 2007-03-14 | Portela & Ca Sa | Process |
| WO2008115706A1 (en) * | 2007-03-16 | 2008-09-25 | Emory University | Methods and compositions for treatment of drug addiction |
| GB0708818D0 (en) * | 2007-05-08 | 2007-06-13 | Portela & Ca Sa | Compounds |
| GB0709695D0 (en) * | 2007-05-21 | 2007-06-27 | Portela & Ca Sa | Process |
| TW200927740A (en) * | 2007-11-13 | 2009-07-01 | Bial Portela & Ca Sa | Process |
| WO2009072915A1 (en) | 2007-12-05 | 2009-06-11 | Bial - Portela & Ca., S.A. | New salts and crystal forms |
| AR070841A1 (es) * | 2008-03-13 | 2010-05-05 | Bial Portela & Ca Sa | Proceso de hidrogenacion catalitica asimetrica |
| US8313984B2 (en) * | 2008-03-19 | 2012-11-20 | Ati Technologies Ulc | Die substrate with reinforcement structure |
| CA2716694A1 (en) | 2008-03-19 | 2009-09-24 | Bial - Portela & C.A., S.A. | Process |
| AR071632A1 (es) | 2008-05-06 | 2010-06-30 | Bial Portela & Ca Sa | Proceso catalitico para hidrogenacion asimetrica en la sintesis de inhibidores de la dopamina-beta-hidroxilasa" |
| CN111808084A (zh) | 2008-11-10 | 2020-10-23 | 阿布特斯生物制药公司 | 用于递送治疗剂的新型脂质和组合物 |
| JP5574480B2 (ja) * | 2009-03-12 | 2014-08-20 | 国立大学法人高知大学 | アミノ基含有アセトン誘導体、及びそれを用いた炭素−炭素結合形成方法 |
| US8927190B2 (en) * | 2010-01-25 | 2015-01-06 | Rohm And Haas Electronic Materials Llc | Photoresist comprising nitrogen-containing compound |
| KR101941467B1 (ko) * | 2010-12-22 | 2019-01-23 | 바이알 - 포르텔라 앤드 씨에이 에스에이 | 결정형 및 이들의 제조방법 |
| JP5981539B2 (ja) | 2011-06-29 | 2016-08-31 | バイアル−ポルテラ アンド シーエー，エス．エー． | プロセス |
| PT2822936T (pt) | 2012-03-07 | 2021-12-02 | Univ Of Delhi | Derivados da aminoquinolina e suas utilizações |
| DK2919780T3 (en) * | 2012-11-14 | 2018-11-26 | Bial Portela & Ca Sa | 1,3-Dihydroimidazole-2-thione derivatives for use in the treatment of pulmonary arterial hypertension and lung injury |
| GB201316410D0 (en) | 2013-09-13 | 2013-10-30 | Bial Portela & Ca Sa | Processes for preparing peripherally-selective inhibitors of dopamine-?-hydroxylase and intermediates for use therein |
| JOP20190049A1 (ar) | 2016-09-23 | 2019-03-20 | Bial Portela & C? S A | مثبطات دوبامين-b-هيدروكسيلاز |
| EP3720856A1 (en) * | 2017-12-04 | 2020-10-14 | BIAL - PORTELA & Cª, S.A. | Dopamine-& x392;-hydroxylase inhibitors |
| GB201810395D0 (en) | 2018-06-25 | 2018-08-08 | Bial Portela & Ca Sa | Formulations comprising dopamine-beta-hydroxylase inhibitors and methods for their preparation |
| WO2020123699A1 (en) * | 2018-12-11 | 2020-06-18 | The Trustees Of Columbia University In The City Of New York | Compounds and compositions that cause mycn and/or cmyc degradation and methods of use thereof |
| GB201908044D0 (en) | 2019-06-05 | 2019-07-17 | Bial Portela & Ca Sa | Dopamine-B-Hydroxylase inhibitors |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE63744T1 (de) | 1985-09-03 | 1991-06-15 | Ciba Geigy Ag | 3-amino-dihydro-(1>-benzopyrane und benzothiopyrane. |
| EP0295401A3 (de) | 1987-04-30 | 1990-03-21 | Wacker-Chemie Gmbh | Verfahren zur Polymerisation von polaren Verbindungen |
| FR2619113B2 (fr) | 1987-05-26 | 1991-06-28 | Exsymol Sa | Nouveaux produits de condensation de silanols, leurs preparation et application |
| US4868210A (en) * | 1988-03-30 | 1989-09-19 | Warner-Lambert Company | Antihyperlipidemic and antiatherosclerotic compounds and compositions |
| US5013854A (en) | 1989-02-02 | 1991-05-07 | Eli Lilly And Company | Process for preparing acid halides |
| SE8904361D0 (sv) | 1989-12-22 | 1989-12-22 | Astra Ab | New chroman and thiochroman derivatives |
| EP0510068B1 (en) * | 1990-01-11 | 1999-04-14 | PHARMACIA & UPJOHN COMPANY | NEW CENTRALLY ACTING 6,7,8,9-TETRAHYDRO-3H-BENZ(e)INDOLE HETEROCYCLICS |
| IT1241988B (it) | 1990-06-15 | 1994-02-02 | Sigma Tau Ind Farmaceuti | 2- amminotetraline-6, 7-sostituite attive come immunomodulanti e composizioni farmaceutiche che le contengono |
| DD297249A5 (de) | 1990-08-07 | 1992-01-02 | Veb Mineralwollewerk Flechtingen Bereich F/E Mineralwolle,De | Verfahren zur automatischen ueberwachung des aushaertegrades an materialbahnen |
| CA2070243A1 (en) * | 1991-06-14 | 1992-12-15 | Akira Shiozawa | Chroman derivatives |
| US5438150A (en) | 1994-04-26 | 1995-08-01 | Syntex (U.S.A.) Inc. | Process for making 1-benzocycloalkyl-1,3-dihydroimidazole-2-thione derivatives |
| FI20040310A7 (fi) * | 1994-04-26 | 2004-02-27 | Syntex Inc | Menetelmä bentsosykloalkyyliatsolitionijohdannaisten valmistamiseksi |
| US5538988A (en) | 1994-04-26 | 1996-07-23 | Martinez; Gregory R. | Benzocycloalkylazolethione derivatives |
| GB2290790A (en) | 1994-06-30 | 1996-01-10 | Merck & Co Inc | Asymmetric synthesis of 6-substituted 2-amino-1,2,3,4-tetrahydronaphthalenes |
| IT1271009B (it) | 1994-09-13 | 1997-05-26 | Zambon Spa | Derivati del benzopirano e del benzotiopirano attivi sul sistema cardiovascolare |
| JPH08259572A (ja) * | 1995-01-24 | 1996-10-08 | Toyama Chem Co Ltd | 新規なセファロスポリン誘導体またはその塩 |
| IT1278045B1 (it) | 1995-03-09 | 1997-11-17 | Sigma Tau Ind Farmaceuti | Uso di 2-amminotetraline-6,7-sostituite per la preparazione di composizioni farmaceutiche atte al trattamento dello shock, e di |
| IT1294931B1 (it) | 1997-09-22 | 1999-04-23 | Sigma Tau Ind Farmaceuti | Derivati della 2-amminotetralina procedimento per la loro preparazione e composizioni farmaceutiche che li contengono, attive nella |
| SE9801726D0 (sv) | 1998-05-15 | 1998-05-15 | Astra Ab | New process |
| CA2338328A1 (en) | 1998-07-21 | 2000-02-03 | Thomas Jefferson University | Small molecule inhibitors of bcl-2 proteins |
| DE69918264T2 (de) | 1999-04-19 | 2004-10-21 | Gen Electric | Bis-Silyl-tertiäre Amines |
| US20010039343A1 (en) | 2000-01-28 | 2001-11-08 | Mulvihill Mark Joseph | Process to intermediates for biologically active compounds |
| DZ3415A1 (fr) * | 2000-08-31 | 2002-03-07 | Chiron Corp | Guanidinobenzamides comme mc4-r agonistes. |
| US20020094316A1 (en) | 2001-01-09 | 2002-07-18 | Shuang Liu | Polypodal chelants for metallopharmaceuticals |
-
2003
- 2003-10-08 US US10/681,578 patent/US7125904B2/en not_active Expired - Lifetime
- 2003-10-10 EP EP07076122A patent/EP1914233B8/en not_active Expired - Lifetime
- 2003-10-10 EP EP03256420A patent/EP1408038B1/en not_active Expired - Lifetime
- 2003-10-10 KR KR1020057006221A patent/KR101155159B1/ko not_active Expired - Fee Related
- 2003-10-10 EP EP07076124A patent/EP1911757B8/en not_active Expired - Lifetime
- 2003-10-10 PL PL376224A patent/PL218537B1/pl unknown
- 2003-10-10 AU AU2003271945A patent/AU2003271945B2/en not_active Ceased
- 2003-10-10 EP EP07076125A patent/EP1908760B1/en not_active Expired - Lifetime
- 2003-10-10 MX MXPA05003847A patent/MXPA05003847A/es active IP Right Grant
- 2003-10-10 RU RU2005114021/04A patent/RU2332416C2/ru active
- 2003-10-10 PT PT103029A patent/PT103029B/pt active IP Right Grant
- 2003-10-10 BR BRPI0315143A patent/BRPI0315143B8/pt not_active IP Right Cessation
- 2003-10-10 EP EP07076123A patent/EP1908759B1/en not_active Expired - Lifetime
- 2003-10-10 WO PCT/GB2003/004430 patent/WO2004033447A1/en not_active Ceased
- 2003-10-10 JP JP2004542666A patent/JP4620464B2/ja not_active Expired - Fee Related
- 2003-10-10 CA CA2501819A patent/CA2501819C/en not_active Expired - Lifetime
-
2006
- 2006-09-20 US US11/533,462 patent/US7259271B2/en not_active Expired - Lifetime
-
2007
- 2007-02-15 GB GB0702982A patent/GB2432159B/en not_active Expired - Fee Related
- 2007-02-15 GB GB0702981A patent/GB2432158B/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT103029A (pt) | Inibidores de dopamina-beta-hidroxilase selectivos perifericamente e metodo para a sua preparacao | |
| DE60328429D1 (de) | Schneideverfahren und -vorrichtung | |
| ITRM20040638A1 (it) | Gel piastrinico semisintetico e metodo per la sua preparazione. | |
| PT1854454E (pt) | Método para a preparação de telmisartan amorfo | |
| BRPI0313238A2 (pt) | método | |
| NO20035272D0 (no) | Intelligent perforerende brönnsystem og fremgangsmåte | |
| GB0406061D0 (en) | Method and system for clearing trades | |
| BR0309190B1 (pt) | Abrasivo revestido e método para formação de um abrasivo revestido | |
| PT1278816E (pt) | Metodo para processar azeitonas | |
| FI20020280A0 (fi) | Putkistoelementti ja menetelmä ja laitteisto sen valmistamiseksi | |
| FI20021196A7 (fi) | Menetelmä luodin laajentamiseksi ja luoti | |
| BR0215897B1 (pt) | prepreg e método para sua produção | |
| BR0318195B1 (pt) | mÉtodo para fabricar um preservativo feminino e preservativo feminino | |
| FI20020162L (fi) | Menetelmä ja laite kuumaliimaukseen | |
| AU2003258941A8 (en) | Metalloproteinase inhibitors and intermediates for preparation thereof | |
| FI20030937L (fi) | Menetelmä ja järjestelmä lyhytviestin välittämiseksi | |
| NO20023358D0 (no) | Metode | |
| FI20022094A0 (fi) | Transponderi ja menetelmä sen valmistamiseksi | |
| FI20030898L (fi) | Menetelmä ja järjestelmä putken supistuksen muodostamiseksi | |
| ITPO20030002A1 (it) | Orecchino perfezionato e metodo per la sua applicazione | |
| PT102754B (pt) | Catecois diterpenicos, processo para a sua preparacao e sua utilizacao | |
| SE0203775D0 (sv) | A new product and a method for its manufacture | |
| ITPC20030016A1 (it) | Metodo per la realizzare figure e disegni | |
| SE0302481D0 (sv) | New product and method | |
| ITMI20021653A1 (it) | Protesi per ernio-allo-plastica e metodo relativo |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| BB1A | Laying open of patent application |
Effective date: 20040209 |
|
| FG3A | Patent granted, date of granting |
Effective date: 20031010 |